Artemid Supports Pflegia’s Growth Strategy

CAPZA announces that Artemid has arranged financing to support the acquisition of Pflegia, Germany’s leading recruitment platform for healthcare professionals, by Ardian Growth.

Founded in 2019 in Germany, Pflegia has established itself as the leading specialist platform for the recruitment of healthcare professionals. Through its innovative reverse-recruitment model, the company enables candidates to choose from several employers, while helping healthcare providers address their growing need for qualified staff. Today, the platform connects a broad network of professionals and healthcare players across Germany.

The company operates in a market underpinned by favourable structural trends, including persistent shortages of healthcare staff, an ageing population and the increasing digitalisation of recruitment processes. Against this backdrop, Pflegia has developed a leading market position, supported by its proprietary technology platform, specialist database and success-based business model.

Historically focused on nurses and care staff, the company is continuing to expand its offering into other medical specialties, further strengthening its positioning in the German healthcare recruitment market.

Through this transaction, Artemid is supporting Ardian Growth’s acquisition of Pflegia and will accelerate the company’s continued development in a market benefiting from attractive growth prospects.

“We are pleased to support Pflegia in this new stage of its development, alongside Ardian Growth. This transaction illustrates Artemid’s ability to provide financing solutions tailored to the needs of high-growth companies and further strengthens our presence in the DACH region, a key market for Artemid’s expansion ambitions.” – Alexander Ball, Director at Artemid

The funds of the Artemid range are managed by the asset management company CAPZA and advised by Artemid SAS, which is a subsidiary of CAPZA and has financial investment advisor status (CIF in France). Artemid SAS is registered by the Orias under the number 14003497 since the 05/28/2014.

Companies shown herein are for illustrative purposes only as of 23/07/2026 and may no longer be in the portfolio later. This information does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.